| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 5,118.66× | 5,118.66× | 2,481.24× | 2,562.03× | 9,821.55× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 520.75× | 520.75× | 523.79× | 734.24× | 1,612.80× | ||
| 1,469.65× | 1,469.65× | 753.21× | 851.13× | 3,447.98× | ||
| 4,169.76× | 4,169.76× | 2,251.82× | 2,445.14× | 7,986.37× | ||
| 0.10× | 0.14× | 0.19× | 0.17× | 0.08× | ||
| 0.05× | 0.05× | 0.07× | 0.06× | 0.03× | ||
| −1.30× | −1.30× | −0.64× | −0.60× | −0.76× | ||
| −1.10× | −1.10× | −0.68× | −0.70× | −0.37× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Inventory Days (DIO) | 9,821.55 | 2,562.03 | 2,481.24 | 5,118.66 | 5,118.66 | |
| Receivable Days (DSO) | 1,612.80 | 734.24 | 523.79 | 520.75 | 520.75 | |
| Payable Days (DPO) | 3,447.98 | 851.13 | 753.21 | 1,469.65 | 1,469.65 | |
| Cash Conversion Cycle (days) | 7,986.37 | 2,445.14 | 2,251.82 | 4,169.76 | 4,169.76 | |
| Working Capital Turnover | 0.08 | 0.17 | 0.19 | 0.14 | 0.10 | |
| Asset Turnover | 0.03 | 0.06 | 0.07 | 0.05 | 0.05 | |
| Cash Conversion (CFO/Net Income) | -0.76 | -0.60 | -0.64 | -1.30 | -1.30 | |
| CFO/EBITDA | -0.37 | -0.70 | -0.68 | -1.10 | -1.10 |